The Oncology Institute Goes Public
Even SPACs are getting involved in the physician medical group market. The Oncology Institute of Hope and Innovation, the largest community oncology practice in California, just announced it was going public in an $842 million merger with DFP Healthcare Acquisitions Corp. (NASDAQ: DFPH), a SPAC sponsored by an affiliate of Deerfield Management Company, L.P. The Oncology Institute was formed just this past March by a joint venture between Havencrest Healthcare Partners, M33 Growth and ROCA Partners. The Oncology Institute has more than 80 board-certified hematologists/oncologists spread throughout 50 offices in Arizona, California and... Read More »
Pear Therapeutics Goes Public
Another week, another SPAC deal. Pear Therapeutics, Inc., a leader in prescription digital therapeutics (PDTs), has announced it is merging with Thimble Point Acquisition Corp. (NASDAQ: THMA), a special purpose acquisition company managed by the Pritzker Vlock Family Office. Pear develops clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. The combined business is expected to have a pro forma equity value of approximately $1.6 billion. The new company, Pear Holding Corp., secured a $125 million PIPE from investors including 5AM Ventures, Arboretum... Read More »
P3 Health Partners Goes Public
The private equity-backed P3 Health Partners is going public in a multi-billion-dollar merger with a SPAC. P3 Health Partners is merging with Foresight Acquisition Corp. (NASDAQ: FORE), and the combined company will have an estimated post-transaction enterprise value of $2.3 billion with an estimated equity value of $2.4 billion from the contribution of at least $180 million in cash proceeds from the transaction. P3 Health Partners was a portfolio company of Chicago Pacific Founders, which is exiting its investment in the company. P3 Health Partners is a patient-centered and physician-led population health management company that supports providers, physicians and practices as they... Read More »Science 37 Goes Public in SPAC Deal
Another week, another SPAC deal. This time, Science 37, Inc. is merging with LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a special purpose acquisition company (SPAC) targeting the biopharma, medical technology, digital health and healthcare services sectors. The transaction values Science 37 at a total enterprise value of $1.05 billion and a fully distributed equity value of approximately $1.3 billion at signing. Science 37 shareholders could also get $125 million in achievement milestones. Science 37 developed the Decentralized Clinical Trial Operating System, which provides workflow coordination, evidence generation and data synchronization, allowing companies to conduct fully... Read More »
Better Therapeutics Goes Public
A San Francisco-based cognitive therapy company is going public through a SPAC. Better Therapeutics, Inc. is merging with Mountain Crest Acquisition Corp II (NASDAQ: MCAD), a publicly traded special purpose acquisition corporation. The deal is valued at $187 million, and existing shareholders will roll over 100% of their equity into the equity of the combined company. Better Therapeutics is a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company’s platform blends clinical, behavioral, and psychological inputs into a series of therapy lessons and skill-building modules designed to isolate... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
